SCHEMBL20888282

SCHEMBL20888282

O=C(/C=C/c1ccccc1)OC[C@H](OC(=O)/C=C/c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
AKR1B10 O60218 4/20 0.52
AKR1B1 P15121 4/20 0.52
ALDH1A1 P00352 2/20 0.48
CA12 O43570 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
RAB9A P51151 2/20 0.46
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
APP P05067 1/20 0.45
MAOB P27338 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19279436 1.00 LMNA (0.55) LMNAAKR1B10AKR1B1ALDH1A1CA12
SCHEMBL20888034 1.00 LMNA (0.55) LMNAAKR1B10AKR1B1ALDH1A1CA12
SCHEMBL20888040 0.91 LMNA (0.49) LMNAAKR1B10AKR1B1ALDH1A1CA12
SCHEMBL20888041 0.91 LMNA (0.49) LMNAAKR1B10AKR1B1ALDH1A1CA12
SCHEMBL19279511 0.88 KMT2A (0.59) LMNAALDH1A1KMT2AMEN1ATM
SCHEMBL19279510 0.88 KMT2A (0.59) LMNAALDH1A1KMT2AMEN1ATM
SCHEMBL20888249 0.88 KMT2A (0.59) LMNAALDH1A1KMT2AMEN1ATM
SCHEMBL20888269 0.88 KMT2A (0.59) LMNAALDH1A1KMT2AMEN1ATM
SCHEMBL22423030 0.87 LMNA (0.50) LMNAAKR1B10AKR1B1ALDH1A1CA12
SCHEMBL20888272 0.86 LMNA (0.47) LMNAAKR1B10AKR1B1ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209639-B1 COMPOUNDS AS ANTI-MALARIALS AND THEIR PROCESS OF PREPARATION COUNCIL SCIENT IND RES (IN) 2020-09-16 EP disclosed
US-20190106380-A1 Aromatic Derivatives As Anti-Malarial COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106380-A1 Aromatic Derivatives As Anti-Malarial TYR, CYP3A43, H1-3 LMNA 2961/4885AKR1B10 1004/4885AKR1B1 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.